Gonadotropin-releasing hormone antagonist (GnRH-ant) protocol has been widely used in assisted reproduction in recent years due to its advantages of non-flare up effect, rapidly and effectively inhibiting the LH surge, reduction of ovarian hyperstimulation syndrome (OHSS) incidence and short treatment period [2]. Here, PLOD1 is linked to ovarian hyperstimulation syndrome.